Phase I trial of Nabpaclitaxel combinated radiotherapy for adenocarcinoma of the esophago-gastric junctio
Phase 1
- Conditions
- Adenocarcinoma of esophago-gastric junction
- Registration Number
- JPRN-UMIN000024088
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1)Nobody performe nabpaclitaxcel before 2)Nobody use blood protacts within 2weeks3)Without drug hypersensitivity 4)Neuropathy level is more than Grade2 5)the patients who have another cancer in the time of entry. 6)With severe complication 7)With infection or chronic inflametory disease 8)Patient use the steroid 9)The patient is pregnancy 10)Male whose partner is pregnancy is possibility from now. 11)It is difficult to decide to take part in this trial with Mentaldisease 12)Docters decides patients are unsuitable for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of maximum tolerated dose and recommended dose
- Secondary Outcome Measures
Name Time Method Evaluation of Toxicity